9
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      5-aza-2'-deoxycytidine activates the p53/p21Waf1/Cip1 pathway to inhibit cell proliferation.

      The Journal of Biological Chemistry
      Antioxidants, pharmacology, Azacitidine, analogs & derivatives, Binding Sites, Blotting, Western, Cell Differentiation, Cell Division, Cell Line, Tumor, Cell Survival, Comet Assay, Cyclin-Dependent Kinase Inhibitor p21, Cyclins, metabolism, DNA Damage, DNA Methylation, Dose-Response Relationship, Drug, Enzyme Inhibitors, Humans, Luciferases, Models, Genetic, Mutagenesis, Site-Directed, Oncogene Proteins, Viral, genetics, Polymerase Chain Reaction, Promoter Regions, Genetic, Repressor Proteins, Sulfites, Time Factors, Transfection, Tumor Suppressor Protein p53

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          In addition to its demethylating function, 5-aza-2'-deoxycytidine (5-aza-CdR) also plays an important role in inducing cell cycle arrest, differentiation, and cell death. However, the mechanism by which 5-aza-CdR induces antineoplastic activity is not clear. In this study, we found that 5-aza-CdR at limited concentrations (0.01-5 microm) induces inhibition of cell proliferation as well as increased p53/p21(Waf1/Cip1) expression in A549 cells (wild-type p53) but not in H1299 (p53-null) and H719 cells (p53 mutant). The p53-dependent p21(Waf1/Cip1) expression induced by 5-aza-CdR was not seen in A549 cells transfected with the wild-type human papilloma virus type-16 E6 gene that induces p53 degradation. Furthermore, deletion analysis and site-directed mutagenesis of the p21 promoter reveals that 5-aza-CdR induces p21(Waf1/Cip1) expression through two p53 binding sites in the p21 promoter. Finally, 5-aza-CdR-induced p21(Waf1/Cip1) expression was dependent on DNA damage but not on DNA demethylation as demonstrated by comet assay and bisulfite sequencing, respectively. Our data provide useful clues for judging the therapeutic efficacy of 5-aza-CdR in the treatment of human cancer cells.

          Related collections

          Author and article information

          Comments

          Comment on this article